Abstract. The neuron-restrictive silencer factor/repressor element 1-silencing transcription factor (NRSF/REST) was originally discovered as a transcriptional repressor of neuronal genes in non-neuronal cells. However, it was recently reported to be abundantly expressed in several types of aggressive cancer cells, as well as in mature neurons. In the present study, the role of NRSF/REST in the human oral squamous cell carcinoma (SCC) KB cell line was evaluated. NRSF/REST was expressed at a higher level in KB cells when compared with that in normal human oral keratinocytes (NHOKs). Knockdown of NRSF/REST by siRNA reduced cell viability only in KB cells in a time-dependent manner, and this effect was due to the activation of apoptosis components and DNA fragmentation. In addition, knockdown of NRSF/REST disrupted the mTOR signaling pathway which is a key survival factor in many types of cancer cells. For example, the phosphorylation of elF4G, elF4E and 4E-BP1 was significantly reduced in the KΒ cells upon NRSF/REST knockdown. These results imply that NRSF/REST plays an important role in the survival of oral cancer cells by regulating the mTOR signaling pathway.
Introduction
Neuron-restrictive silencer factor (NRSF), also called repressor element 1 (RE-1) silencing transcription factor (REST), is a major transcriptional repressor for neuron-specific genes in non-neuronal and neuronal progenitor cells (1-3) through histone deacetylation, chromatin remodeling, methylation and other mechanisms (4) (5) (6) . NRSF/REST is a 116-kDa protein that contains a DNA-binding domain with 8 zinc fingers and 2 repressor domains: one at the amino-terminus and the other at the carboxy-terminus of the protein (1, 7, 8) . NRSF/REST binds to a 21-bp consensus sequence of the neural restrictive silencer element (NRSE), also known as the RE-1, in the regulatory regions of many neuron-specific genes: ion channels, neurotransmitter and neurotropic receptors, neuronal cell adhesion molecules, neuronal growth factors, neuronal cytoskeleton, and others (5, 9) . NRSF/REST mediates transcription repression through the association of its amino terminal repression domain with the mSin3/histone deacethylase 1/2 (HDAC 1/2) complex (10) (11) (12) and through the association of its carboxy terminal repression domain with the CoREST/HDAC complex (13, 14) .
Although NRSF/REST was first identified as a transcriptional repressor of neuronal genes in non-neuronal cells, recent studies have revealed seemingly paradoxical roles in tumor suppression and cancer progression.
NRSF/REST has a tumor-suppressor function in colorectal cancer (15) . In RNAi-based genetic screening for tumor-suppressor genes in human mammary epithelial cells, NRSF/REST was 1 of 5 candidate genes that survived validation. Anchorage-independent growth was facilitated by knockdown of NRSF/REST in these cells, but suppressed by overexpression of NRSF/REST in a colon cancer cell line. In support of this view, NRSF/REST was mutated in several primary tumor specimen and colon cancer cell lines. The expression of a mutated form, a dominant-negative form of NRSF/REST, caused a stimulated PI(3)K pathway and subsequent transformation.
In contrast, NRSF/REST has an oncogenic function in medulloblastoma. Human medulloblastoma cell lines and many human medulloblastomas overexpress NRSF/REST compared with neuronal cells or fully differentiated neurons (16) (17) (18) . NRSF/REST-expressing human medulloblastoma cells did not express NRSF/REST target genes that are important in tumorigenesis. In support of this view, REST-VP16, a recombinant transcription factor, by replacing the repressor domains of NRSF/REST with the activation domain of the herpes simplex virus protein VP16, operates through RE1/NRSE, competes with endogenous NRSF/REST for DNA binding and activates NRSF/REST target genes. As a result, the expression of REST-VP16 in these cells was shown to cause blockade of tumorigenicity (18) (19) (20) .
In addition, NRSF/REST plays an oncogenic role in several neuroblastoma cells. Overexpression of NRSF in neuroblastoma cells was accompanied with repression of neuronal differentiation genes. Furthermore, NRSF/REST expression decreased and neuronal markers increased during differentiation-induction in these cells. Therefore, the overexpression of NRSF in neuronal cells blocks these cells from neuronal differentiation and produces the cancerous phenotype (21, 22) .
Oral cancer, also called oral cavity cancer, is squamous cell carcinoma (SCC) that originates from squamous epithelium of the oral tongue and floor of the mouth (23) , and is one of the top most commonly diagnosed cancer types in the world (24) . Oral SCC represents 1~2% of all human malignancies, whereas survival rates are among the lowest of major cancers. It is characterized by a high degree of local invasiveness and a high rate of metastasis to cervical lymph nodes. The migration of oral SCC into maxillary and mandibular bones is a common clinical problem. Current treatment, including surgical removal of the lesion, is inadequate due to the wide exposure of carcinogens over a large mucosal surface. Hence, there is an unmet medical need to develop better diagnostic measures and therapeutic targets.
In the present study, we studied the roles of NRSF/NRST in regard to cell survival, apoptosis, and translational regulation in an oral cancer cell line. The results demonstrated that NRSF/REST was directly associated with the survival of oral cancer cells through the regulation of the mTOR signaling pathway.
Materials and methods
Cell culture. Normal human oral keratinocytes (NHOKs) were purchesed from the ScienCell Research Laboratories (Carlsbad, CA, uSA). NHOKs were maintained in KGM and a supplementary growth factor bullet kit (Clonetics Corp., San Diego, CA, uSA). Human oral squamous carcinoma KB cells were grown in MEM medium (Gibco, Grand Island, NY, uSA) supplemented with 10% heat-inactivated fetal bovine serum, 100 u/ml penicillin/100 µg/ml streptomycin (Gibco) and 0.1 µM MEM non-essential amino acids (Gibco) at 37˚C in a humidified atmosphere of 5% CO 2 .
siRNAs and transfection. The day before transfection, KB cells or NHOKs were plated in 6-well plates at a density of 7x10 5 cells in each well. After overnight incubation, cells were transfected with NRSF siRNA using Lipofectamine 2000 transfection reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) according to the manufacturer's instructions. Briefly, NRSF siRNA and Lipofectamine 2000 were each diluted in 50 µl Opti-MEM I and incubated for 5 min at room temperature. The diluted NRSF siRNA and Lipofectamine 2000 were combined and then incubated for 20 min at room temperature. After incubation, NRSF siRNA/Lipofectamine 2000 complexes were added to each well. The cells were incubated at 37˚C in a humidified atmosphere of 5% CO 2 . NRSF siRNA and negative control siRNA were purchased from Bioneer (AccuTarget™ Human genome-wide predesigned siRNA; no. 1128323, AccuTarget™ negative control siRNA; SN-1002, Daejeon, Korea). The concentrations of siRNAs were optimized to 50 pmol/well. After transfection, on days 1, 2, 3 and 4, the cells were re-transfected with the same siRNA for thorough knockdown of NRSF. siRNA-transfected cells were harvested at each days. Total proteins were prepared using RIPA buffer.
MTT assay. The day before transfection, KB cells and NHOKs were plated in 24-well plates at a density of 1.5x10 5 cells in each well. After overnight incubation, cells were transfected with NRSF siRNA using Lipofectamine 2000 transfection reagent according to the manufacturer's instructions. On days 1, 2, 3 and 4, cells were re-transfected with the same siRNA. Fifty microliters of the 5 µg/ml stock solution of 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (Sigma-Aldrich, St. Louis, MO, uSA) was added to each well, and the cells were incubated at 37˚C in a humidified atmosphere of 5% CO 2 for 4 h. After removal of the supernatant, 0.5 µl of isopropanol was added to each well. Plates were incubated at room temperature on a horizontal shaker for 20 min, and the optical density was measured in absorbance at 562 nm with a microplate reader (EL311SX; BIO TEX Instruments Inc., Cortland, NY, uSA). Independent experiments were performed in triplicate and the Student's t-test was used for statistical analysis.
Western blot analysis. KB cells were plated in 6-well plates at a density of 7x10 5 cells/well. After overnight incubation, the cells were transfected with NRSF siRNA using Lipofectamine 2000 transfection reagent according to the manufacturer's instructions. On days 1, 2, 3 and 4, the cells were re-transfected with the same siRNA. siRNA-transfected cells were harvested on each day. For harvesting, the cells were washed twice with PBS. Cells were lysed in RIPA buffer [50 µM Tris-HCl pH 7.5, 150 µM NaCl, 0.25% sodium deoxycholate, 0.1% Nonidet P-40, 0.1% SDS, 50 µM NaF, 0.5 µM phenylmethylsulfonyl fluoride, 10 µM Na 3 VO 4 and Complete Mini protease inhibitor cocktail (Roche, Mannheim, Germany)] for 30 min on ice. The supernatant was transferred to a new tube after centrifugation at 15,000 x g for 15 min at 4˚C (Sorvall centrifuge, Bad Homburg, Germany). The protein concentration was quantified by the BCA protein assay (Pierce, Rockford, IL, USA) using BSA as a standard. Approximately 50 µg of protein from each lysate was solubilized in Laemmli sample buffer and then loaded onto 3-8 or 4-20% gradient gel (Invitrogen Life Technologies). The protein was separated by electrophoresis at 120 V for 90 min. The separated proteins were transferred to a polyvinylidene difluride nanofiber membrane (Amomedi, Gwangju, Korea). The membranes were blocked for 1 h with 5% milk at room temperature, followed by incubation overnight with primary antibodies against each of the following: anti-NRSF (07-579; upstate Biotechnology, Billerica, MA, uSA), anti-phospho-eIF4G (#2441), anti-cleaved caspase-9 (#9501), anti-cleaved caspase-7 (#9491) (all from Cell Signaling Technology, Danvers, MA, uSA), anti-β-actin (sc-47778, Santa Cruz Biotechnology, Santa Cruz, CA, uSA). After washing 3 times with TBST (0.1% Tween-20, 50 µM Tris-HCl pH 7.5, 150 µM NaCl), the membranes were incubated for 2 h with secondary antibodies and then washed 3 times with TBST.
The membranes were detected using the westSave up ECL kit (ABFrontier, Seoul, Korea) and exposed to Kodak BioMax Light Film (Carestream Health Inc., Rochester, NY, uSA).
DNA fragmentation assay. KB cells were plated in 6-well plates at a density of 7x10 5 cells in each well. Transfection of siRNAs was also performed as described previously. Cells were washed twice with PBS and pelleted by centrifugation at 400 x g for 3 min. Cell pellets were lysed in lysis buffer (10 µM Tris-Cl, pH 7.5, 10 µM EDTA, 0.5% Triton X-100) and kept on ice for 30 min. RNase A was added to a final concentration of 0.5 µg/ml and incubated for 1 h at 37˚C, followed by the addition of proteinase K to a final concentration of 0.2 µg/ml and incubated for 8 h at 50˚C. DNA was extracted using phenol:chloroform:isoamyl alcohol (25:24:1). DNA was precipitated with an equal volume of isopropanol, stored at -70˚C for 24 h, and centrifuged at 15,000 x g for 15 min at 4˚C. The precipitated DNA was air-dried, resuspended in 30 µl TE buffer and quantified by absorbance at 260 nm in a UV spectrophotometer (BioPhotometer, Eppendorf, Hamburg, Germany). Ten micrograms of DNA was applied to 1.5% agarose gel and electrophoresed at 50 V for 50 min. DNA fragments were visualized using a uV transilluminator after ethidium bromide staining.
Statistical analysis. The data are reported as the mean ± SD of 3 individual experiments performed in triplicate and presented as the mean. Statistical analysis was performed by a Student's t-test, and a P-value <0.05 was considered significant.
Results

Silencing of NRSF/REST expression decreases oral cancer cell viability.
First, to verify whether NRSF/REST is expressed in KB cells and NHOKs, western blot analysis was performed. The data showed that KB carcinoma cells expressed NRSF/REST at a higher level than that in the NHOKs (Fig. 1A) . To investigate the role of NRSF/REST in the cell viability of KB cells and NHOKs, we used siRNA to knockdown endogenous NRSF/REST. Specific suppression of NRSF/REST was assayed by western blot analysis. The expression level of NRSF/REST protein was significantly reduced in the NRSF/REST siRNA-transfected group compared to both the non-transfected and negative siRNA-transfected group. The data showed that NRSF/REST siRNA was successful in the knockdown of NRSF/REST protein expression (Fig. 1A) .
Consequently, cell viability of these cells after NRSF/REST siRNA transfection was measured by MTT assay. Cell viability was significantly decreased up to 50% by NRSF/REST siRNA in the KB cells, whereas there was no effect of NRSF/REST siRNA on the cell viability of the NHOKs (Fig. 1B) . This result indicates that NRSF/REST is important for KB cancer cell survival but is not for the normal oral cell line.
Downregulation of cell viability by NRSF/REST knockdown is due to apoptosis.
To address whether the mechanism of the cytotoxic effect of NRSF/REST knockdown on the KB cells was related to apoptosis, the expression of apoptotic marker genes was determined by western blot analysis, and a DNA fragmentation assay was performed. The expression of cleaved caspase-9 and -7, activated forms of caspase-9 and -7, respectively, were significantly increased in the KB cells 2 days after transfection with NRSF/REST siRNA ( Fig. 2A) . In addition, caspase-3, the activator of caspase-activated DNase (CAD) or DNA fragmentation factor 40 (DFF40), was induced from day 3 following transfection with NRSF/REST siRNA ( Fig. 2A) and this was correlated to the appearance of fragmented DNA (Fig. 2B ) which is one of the major hallmarks of apoptotic cells.
NRSF/REST regulates the phosphorylation of eIF4G.
A recent study demonstrated that knockdown of NRSF/REST induced a decrease in eIF4G phosphorylation, a key downstream component of mTOR, in human neuroblastoma cells (25) . Since the mTOR signaling pathway has a central role in the regulation of cancer cell growth by control of the initiation of mRNA translation into protein, we investigated the effect of NRSF/REST knockdown on the level of elF4G phosphorylation in both the KB cells and NHOKs. As shown in Fig. 3 , western blot analysis indicated that the level of phosphorylated elF4G was significantly reduced in the NRSF/REST siRNA-treated KB cells but not in the NHOKs while the expression level of total eIF4G was not changed by the NRSF/REST siRNA transfection in both cell types.
NRSF/REST regulates the mTOR signaling pathway. eIF4G is one of the fundamental downstream targets of the mTOR signaling pathway (26) . To confirm that the downregulation of eIF4G phosphorylation by knockdown of NRSF/REST is associated with the phosphorylation of mTOR, western blot analysis was performed. The phosphorylation of mTOR was significantly decreased following knockdown of NRSF/REST in the KB cells whereas the phosphorylation of mTOR after knockdown of NRSF/REST was slightly increased in the NHOKs (Fig. 4A) . However, the endogenous levels of total mTOR were not affected by NRSF/REST siRNA in these cells (Fig. 4A) .
In addition to elF4G, 4E-BP1 and elF4E are downstream components of the mTOR signaling pathway that directly activate the caspase-dependent translation process (27) . To determine whether NRSF/REST knockdown affects these 2 downstream components of the mTOR signaling pathway, the phosphorylation of 4E-BP1 and eIF4E was assayed by western blot analysis. The phosphorylation of 4E-BP1 and eIF4E was significantly reduced in the KB cells with knockdown of the NRSF/REST compared to the negative siRNA-transfected cells. However, the endogenous levels of 4E-BP1 and eIF4E were not changed by NRSF/REST siRNA transfection (Fig. 4B) . All together, these results indicate that NRSF/REST controls the mTOR signaling pathway for oral cancer cell survival. 
Discussion
NRSF/REST is a transcription factor that plays a major role in the repression of neuron-specific genes in non-neuronal cells via binding to the neuron restrictive silencer element (1) (2) (3) and is associated with various types of cancers (15, 16, (28) (29) (30) (31) . It has been known to confer both tumorigenic and tumorsuppressor effects, depending on the cell type (20) . Our results showed that KB oral cancer cells overexpressed NRSF/REST when compared with the normal oral keratinocytes, and siRNA-mediated knockdown of NRSF/REST significantly decreased KB cell viability. The activation of caspase components and fragmentation of DNA indicated that apoptosis was the mechanism of the observed KB cell death. Thus, we suggest that NRSF/REST may have an oncogenic function in KB oral cancer cells.
Although the association of NRSF/REST in various cancer types has been reported, the mechanism of action of NRSF/REST in cancer progression and tumorigenesis remains unknown. Recently, our laboratory studied the role of NRSF/REST in post-transcriptional regulation and found that it enhanced the phosphorylation of the eukaryotic translation initiation factor, elF4G (25) . Since elF4G is one of the downstream components in the mTOR signaling pathway and mTOR is known to be a key survival factor in many cancer cells (32,33), we reasoned that NRSF/REST may exert its oncogenic activity via the mTOR signaling pathway in KB oral cancer cells. As expected, siRNA-mediated NRSF/REST knockdown reduced the phosphorylation of elF4G and mTOR, and significantly inhibited the activation of other downstream components (elF4G, elF4E, and 4E-BP1) ( Fig. 3 and 4 ) strongly suggesting that NRSF/REST controls the mTOR pathway in KB oral cancer cells.
It is important to point out that the effects of NRSF/REST knockdown described in the present study are reminiscent of that of rapamycin in MDA-MB 231 breast cancer cells (34) . This study reported that a high dose of rapamycin induced apoptosis in MDA-MB231 cells and it was correlated with suppression of the phosphorylation of the mTOR substrate, 4E-BP1. Furthermore, the study provided evidence that complete dissociation of Raptor from the mTOR complex is necessary for rapamycin-mediated apoptosis in MDA-MB-231 cells. Therefore, it is tempting to speculate that NRSF/REST knockdown in KB oral cancer cells may disrupt the formation of the active mTOR complex by dysregulating components of the mTOR complex such as Raptor.
Notably, NRSF/REST knockdown did not cause cell death and mTOR regulation in NHOKs while they expressed detectable amount of NRSF/REST although much lower than that in KB cancer cells. It has been shown that, when overexpressed, NRSF/REST can be localized in both the nucleus and cytoplasm; cytoplasmic NRSF/REST can upregulate transla- tion and enhance elF4G phosphorylation in neuroblastoma cells (25) . Thus, aberrant high expression of NRSF/REST in KB oral cancer cells compared to normal NHOKs may explain the role of NRSF/REST in cell survival by controlling the mTOR pathway only in KB cells.
In summary, we demonstrated that NRSF/REST functions as a regulator of the mTOR signaling pathway in KB oral cancer cells and is important for cancer cell survival. Further delineation of the mechanism of NRSF/REST action in the mTOR signaling pathway may provide insight into the development of a novel oral cancer treatment.
